Daudén, Esteban http://orcid.org/0000-0002-0676-1260
Belinchón, I. http://orcid.org/0000-0002-6007-7320
Colominas-González, E. http://orcid.org/0000-0002-6835-2868
Coto, P.
de la Cueva, P. http://orcid.org/0000-0003-4807-3551
Gallardo, F. http://orcid.org/0000-0002-6735-8459
Poveda, J. L. http://orcid.org/0000-0003-1800-6198
Ramírez, E. http://orcid.org/0000-0003-3053-7426
Ros, S. http://orcid.org/0000-0002-6267-1059
Ruíz-Villaverde, R. http://orcid.org/0000-0002-0381-6174
Comellas, M. http://orcid.org/0000-0002-5275-9882
Lizán, Luís http://orcid.org/0000-0001-6039-2454
Article History
Received: 13 July 2023
Accepted: 12 June 2024
First Online: 24 June 2024
Competing interests
: ED has the following conflict of interests: Advisory Board member, consultant, grants, research support, participation in clinical trials, honorarium for speaking, research support, with the following pharmaceutical companies: Abbvie/Abbott, Almirall, Amgen-Celgene, Janssen-Cilag, Leo-Pharma, Novartis, Pfizer, MSD-Schering-Plough, Lilly, UCB, Brystol-Myers and Boehringer-Ingelheim. IB acted as a consultant and/or speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis, including Janssen Pharmaceuticals Inc, Almirall SA, Lilly, AbbVie, Novartis, Celgene, Biogen, Amgen, Leo-Pharma, UCB, Pfizer-Wyeth, and MSD. ECG has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Amgen and Abbvie, and has received support for attending meetings and/or travels from UCB pharma. PC has received payment or honoraria for lectures, presentations, speakers bureaus, manuscripts writing or educational events from Almirall, Abbvie, Amgen-Celgene, Sanofi. PDLC has received consulting fees or honoraria for lectures, presentations, speakers bureaus manuscript writing or educational events or support for attending meetings and/or travel or has participated on Data Safety Monitoring Board or Advisory Board from Abbvie, Almirall, Amgen, Boehringer, Celgene, Janssen., LEO Pharma, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi and UCB. SR has received payment or honoraria for lectures, presentations, speakers bureaus manuscript writing or educational events from Almirall, Abbvie, Leo Pharma, Lilly, UCB, Novartis, BMS, Boehringer. LL and MC work for an independent research entity that received funding from Almirall to coordinate and conduct the project. FG, ER, JLP and RRV declare no conflicts of interest in this work.